Warning letter
Vitalab Pharmacy, Inc.: warning letter of Jan 10, 2019
FDA warning letter 570563 · Center for Drug Evaluation and Research
Key facts
| Reference number | 570563 |
|---|---|
| Company | Vitalab Pharmacy, Inc. |
| Subject | Drug Product/Adulterated |
| Issue date | Jan 10, 2019 |
| Posted date | Feb 12, 2019 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| Inspection city | Phoenix |
| Inspection ZIP | 85032-2240 |
| Inspection start date | Mar 26, 2018 |
| Letter on fda.gov | fda.gov |
At a glance
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: